In vivo experiments using different xenograft models derived from patient tumors, including oral squamous cell carcinoma and oral SAS cells, also demonstrate reduced PD-L1 expression, decreased tumor growth, and diminished cell proliferation [240]. The gene discussed is CD274; the disease is neoplasm.